Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9268379 | Journal of Clinical Virology | 2005 | 6 Pages |
Abstract
We demonstrated that the prevalence of virologic response decreased at week 72 and disappeared after 96 weeks of treatment. This slower CD4 repopulation correlated with a lower thymic volume compared to those with complete response. Also, the probability of having virologic response did not correlate with protease inhibitor-based (PI-based) regimens or HCV coinfection. On the other hand, immune response in our cohort could be easily attributable to a simple mechanism, i.e. irregular treatment compliance.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Sonia Molina-Pinelo, Manuel Leal, Natalia Soriano-Sarabia, Sonia Gutiérrez, Gerónimo Fernandez, Ma Ángeles Muñoz-Fernández, Eduardo Lissen, Alejandro Vallejo,